Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF. [PDF]
PLoS ONE, 2012 Hemangiomas are tumors formed by hyper-proliferation of vascular endothelial cells. This is caused by elevated vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2 (VEGFR2).
Damian Medici, Bjorn R Olsen
doaj +4 more sources
Vascular endothelial growth factor (VEGF) and prostate pathology [PDF]
International Brazilian Journal of Urology, 2010 PURPOSE: Previous studies suggest that vascular endothelial growth factor (VEGF) circulating levels might improve identification of patients with prostate cancer but results are conflicting.
Francisco Botelho +5 more
doaj +6 more sources
Association of vascular endothelial growth factor (VEGF) protein levels and gene polymorphism with the risk of chronic kidney disease [PDF]
Libyan Journal of Medicine, 2023 Vascular endothelial growth factor (VEGF) is a heparin-specific growth factor specific for vascular endothelial cells and induces angiogenesis via binding to vascular endothelial growth factor receptor (VEGFR).
Yipin Liu +4 more
doaj +2 more sources
Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease. [PDF]
Pharmaceuticals (Basel)In this Special Issue of Pharmaceuticals, we present four reviews and seven original articles addressing recent aspects of research on Vascular Endothelial Growth Factors (VEGFs) and their receptors, from clinical practice to fundamental studies in new drug development [...]
Broussy S.
europepmc +4 more sources
Expression of vascular endothelial growth factor (VEGF) in equine sarcoid [PDF]
BMC Veterinary Research, 2018 Background Sarcoids are the mostcommon skin tumors in horses, characterized by rare regression, invasiveness and high recurrence following surgical intervention and Delta Papillomaviruses are widely recognized as the causative agents of the disease.
Manuela Martano +6 more
doaj +4 more sources
Increase in Vascular Endothelial Growth Factor (VEGF) Expression and the Pathogenesis of iMCD-TAFRO [PDF]
BiomedicinesSrkalovic G +3 more
europepmc +3 more sources
VEGF-A, HGF and bFGF are involved in IL-17A-mediated migration and capillary-like vessel formation of vascular endothelial cells [PDF]
Iranian Journal of Immunology, 2021 Background: Interleukin (IL)-17A possesses biological activities to promote vascular endothelial cell migration and microvessel development. Objective: To clarify which angiogenic factors are involved in IL-17A-modified angiogenesis-related functions of ...
Muneo Numasaki, Koyu Ito
doaj +1 more source
Silicone Oil Droplets in the Vitreous After an Anti-vascular Endothelial Growth Factor (VEGF) Injection: A Complication of Syringe Lubrication. [PDF]
CureusKamath S, Charlotte A, Nandan N.
europepmc +2 more sources
A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma. [PDF]
EJHaemKnop S +19 more
europepmc +3 more sources
Vascular endothelial growth factors (VEGFs) and stroke [PDF]
Cellular and Molecular Life Sciences, 2013 Vascular endothelial growth factors (VEGFs) have been shown to participate in atherosclerosis, arteriogenesis, cerebral edema, neuroprotection, neurogenesis, angiogenesis, postischemic brain and vessel repair, and the effects of transplanted stem cells in experimental stroke.
David A, Greenberg, Kunlin, Jin
openaire +2 more sources